Thyroid Function Test Market Report 2026

The thyroid function test market size has grown strongly in recent years. It will grow from $1.81 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to rising prevalence of thyroid disorders, increasing awareness of endocrine health, expansion of diagnostic laboratory networks, availability of standardized thyroid assays, routine inclusion of tsh testing in health checkups.

The thyroid function test market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising demand for point-of-care thyroid testing, expansion of automated laboratory workflows, growing focus on early disease detection, increasing integration of digital diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity immunoassays, rising demand for early thyroid disorder screening, growing use of automated diagnostic platforms, expansion of comprehensive thyroid test panels, enhanced focus on diagnostic accuracy and standardization.

The increasing incidence of thyroid disorders is expected to drive growth in the thyroid function test market in the coming years. Thyroid disorders are conditions that affect the thyroid gland, a butterfly-shaped organ located at the front of the neck. Factors contributing to the rise in thyroid disorders include dietary changes, radiation exposure, hormonal fluctuations, environmental influences, and autoimmune diseases. Thyroid function tests are essential for diagnosing and managing these disorders, as they provide critical information about thyroid hormone levels and the presence of antibodies, helping guide treatment decisions, monitor therapy effectiveness, and prevent complications. For example, in April 2024, the Journal of Global Health (JoGH), a UK-based non-profit organization, reported that the number of thyroid cancer cases is projected to reach approximately 305,078 by 2030. Therefore, the rising incidence of thyroid disorders is driving the growth of the thyroid function test market.

Key companies in the thyroid function test market are focusing on innovative technologies, such as RNA sequencing, to improve the accuracy of cancer fusion detection across multiple solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput method that analyzes both the quantity and sequence of RNA in a sample, providing insights into gene expression and the overall transcriptome. For instance, in May 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test offers fusion reporting for all solid tumors and is particularly useful in detecting fusions in cancers such as non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

In January 2023, Thermo Fisher Scientific, a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion. This strategic acquisition allows Thermo Fisher to expand its diagnostic portfolio, enhance patient care, and leverage growth opportunities in the specialty diagnostics sector. The Binding Site Group, based in the UK, specializes in the development and manufacture of immunodiagnostic products, including tests for thyroid function.

Major companies operating in the thyroid function test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, Merck KGaA, BioMérieux Inc., WerfenLife SA, DiaSorin SpA, Beckman Coulter Life Sciences, Autobio Diagnostics Co. Ltd., Quidel Corporation, Boditech Med Inc., Cortez Diagnostics, Qualigen Inc., Ortho Clinical Diagnostics, Bio‑Rad Laboratories Inc., Sysmex Corporation, Randox Laboratories Ltd., Tosoh Corporation, Fujirebio.

North America was the largest region in the thyroid function test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid function test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thyroid function test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the thyroid function test market by increasing costs of imported reagents, antibodies, assay kits, laboratory analyzers, and electronic diagnostic components. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported testing consumables, while Asia-Pacific faces pricing pressure on test kit manufacturing and exports. These tariffs are raising operational costs and influencing test pricing structures. However, they are also encouraging local reagent manufacturing, regional diagnostic kit production, and investments in domestic laboratory supply chains, improving long-term market resilience.

The thyroid function test market research report is one of a series of new reports that provides thyroid function test market statistics, including thyroid function test industry global market size, regional shares, competitors with a thyroid function test market share, detailed thyroid function test market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid function test industry. This thyroid function test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Thyroid function tests (TFTs) are a set of blood tests used to evaluate the performance of the thyroid gland, which is essential for regulating metabolism and various bodily functions. These tests measure levels of thyroid hormones and other substances that affect thyroid activity to help diagnose thyroid disorders and monitor treatment.

The main types of thyroid function tests include thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), free triiodothyronine (FT3), and free thyroxine (FT4). A TSH test measures the level of TSH in the blood, which is produced by the pituitary gland and stimulates the thyroid to produce hormones. These tests are indicated for conditions such as hypothyroidism, hyperthyroidism, thyroid cancer, and others, and are used by end-users including clinics, research organizations, diagnostic laboratories, and hospitals.

The thyroid function test market includes revenues earned by entities by providing thyroid antibody tests, total triiodothyronine test, total thyroxine test, and thyroglobulin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.